Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thromboplastin | 13 | 2015 | 291 | 2.240 |
Why?
|
Platelet Function Tests | 3 | 2020 | 270 | 1.630 |
Why?
|
Platelet Adhesiveness | 18 | 2020 | 161 | 1.600 |
Why?
|
Platelet Aggregation | 18 | 2020 | 798 | 1.550 |
Why?
|
Hemolytic-Uremic Syndrome | 6 | 2019 | 110 | 1.520 |
Why?
|
von Willebrand Diseases | 3 | 2020 | 127 | 1.090 |
Why?
|
Shiga Toxin 2 | 3 | 2019 | 21 | 0.960 |
Why?
|
Blood Platelets | 15 | 2019 | 2508 | 0.950 |
Why?
|
Lipoproteins | 8 | 2015 | 878 | 0.940 |
Why?
|
Shiga Toxin 1 | 4 | 2015 | 42 | 0.930 |
Why?
|
Endothelium, Vascular | 19 | 2015 | 4456 | 0.900 |
Why?
|
Thrombosis | 13 | 2019 | 2968 | 0.840 |
Why?
|
Hemostasis | 5 | 2012 | 458 | 0.820 |
Why?
|
Mannose-Binding Lectin | 2 | 2019 | 150 | 0.790 |
Why?
|
Hemorheology | 3 | 2012 | 145 | 0.690 |
Why?
|
von Willebrand Factor | 3 | 2020 | 669 | 0.690 |
Why?
|
Contrast Media | 16 | 1996 | 5300 | 0.640 |
Why?
|
Shiga Toxin | 2 | 2019 | 34 | 0.630 |
Why?
|
Microscopy, Video | 2 | 2020 | 245 | 0.570 |
Why?
|
Umbilical Veins | 5 | 2008 | 433 | 0.510 |
Why?
|
Kidney Glomerulus | 4 | 2019 | 697 | 0.500 |
Why?
|
Thrombophilia | 5 | 2010 | 305 | 0.480 |
Why?
|
Retinoblastoma | 7 | 2014 | 318 | 0.460 |
Why?
|
Microfluidics | 1 | 2019 | 662 | 0.460 |
Why?
|
Rheology | 5 | 2012 | 345 | 0.440 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1097 | 0.430 |
Why?
|
von Willebrand Disease, Type 1 | 1 | 2012 | 5 | 0.420 |
Why?
|
Blood Viscosity | 1 | 2012 | 124 | 0.400 |
Why?
|
Escherichia coli Infections | 3 | 2019 | 532 | 0.390 |
Why?
|
Blood Flow Velocity | 7 | 2020 | 1423 | 0.360 |
Why?
|
Blood Coagulation | 8 | 2013 | 1127 | 0.350 |
Why?
|
Hemorrhage | 4 | 2017 | 3461 | 0.320 |
Why?
|
Endothelial Cells | 3 | 2019 | 3479 | 0.290 |
Why?
|
Saphenous Vein | 2 | 2000 | 532 | 0.290 |
Why?
|
Thrombolytic Therapy | 7 | 2019 | 2161 | 0.290 |
Why?
|
Ioxaglic Acid | 9 | 1996 | 30 | 0.260 |
Why?
|
Tissue Plasminogen Activator | 4 | 2019 | 1261 | 0.260 |
Why?
|
Fibrinolytic Agents | 8 | 2022 | 2158 | 0.250 |
Why?
|
Blood Coagulation Disorders | 2 | 2002 | 337 | 0.250 |
Why?
|
Cell Degranulation | 2 | 1996 | 287 | 0.250 |
Why?
|
Stroke | 7 | 2019 | 9981 | 0.230 |
Why?
|
Retinal Neoplasms | 3 | 2014 | 144 | 0.230 |
Why?
|
Iohexol | 9 | 1996 | 196 | 0.230 |
Why?
|
Platelet Activation | 3 | 1996 | 673 | 0.220 |
Why?
|
Stress, Mechanical | 6 | 2020 | 1686 | 0.220 |
Why?
|
Escherichia coli O157 | 1 | 2002 | 54 | 0.200 |
Why?
|
Factor Xa | 5 | 2005 | 162 | 0.200 |
Why?
|
Fibrin | 3 | 2017 | 506 | 0.200 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2015 | 4420 | 0.200 |
Why?
|
Antiphospholipid Syndrome | 1 | 2022 | 173 | 0.190 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2022 | 139 | 0.190 |
Why?
|
Syringes | 2 | 1991 | 56 | 0.190 |
Why?
|
Blood Coagulation Factors | 2 | 2006 | 355 | 0.190 |
Why?
|
Thromboembolism | 2 | 2019 | 986 | 0.190 |
Why?
|
Coronary Thrombosis | 2 | 1994 | 495 | 0.180 |
Why?
|
Diatrizoate | 6 | 1996 | 86 | 0.170 |
Why?
|
Heparin | 6 | 2022 | 1637 | 0.170 |
Why?
|
Angiography | 3 | 2022 | 1639 | 0.160 |
Why?
|
Epoprostenol | 4 | 1990 | 254 | 0.160 |
Why?
|
Eye Neoplasms | 3 | 1989 | 313 | 0.160 |
Why?
|
Humans | 81 | 2022 | 744343 | 0.150 |
Why?
|
Hemophilia B | 1 | 2017 | 81 | 0.150 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 1994 | 1873 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 551 | 0.150 |
Why?
|
Coronary Angiography | 3 | 1996 | 4577 | 0.150 |
Why?
|
Gene Expression Regulation | 3 | 2013 | 12072 | 0.150 |
Why?
|
RNA, Messenger | 6 | 2015 | 13033 | 0.140 |
Why?
|
Complement C3d | 1 | 2016 | 21 | 0.140 |
Why?
|
Cells, Cultured | 13 | 2015 | 19229 | 0.140 |
Why?
|
Brain Ischemia | 4 | 2019 | 3265 | 0.140 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 1994 | 293 | 0.130 |
Why?
|
Nephrotic Syndrome | 2 | 2008 | 389 | 0.130 |
Why?
|
Blood Circulation | 4 | 1988 | 251 | 0.130 |
Why?
|
Cell Membrane | 3 | 2015 | 3748 | 0.130 |
Why?
|
Coagulants | 1 | 2015 | 49 | 0.130 |
Why?
|
Coronary Circulation | 2 | 1991 | 1572 | 0.130 |
Why?
|
Pulmonary Embolism | 3 | 2022 | 2376 | 0.130 |
Why?
|
Endothelium | 3 | 1989 | 778 | 0.120 |
Why?
|
Child, Preschool | 13 | 2020 | 41006 | 0.120 |
Why?
|
Child | 21 | 2022 | 77709 | 0.120 |
Why?
|
Pulsatile Flow | 1 | 1995 | 332 | 0.120 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2015 | 428 | 0.120 |
Why?
|
Anticoagulants | 6 | 2022 | 4599 | 0.120 |
Why?
|
Hyperhomocysteinemia | 1 | 2014 | 124 | 0.120 |
Why?
|
Infant, Newborn | 11 | 2018 | 25625 | 0.120 |
Why?
|
Intracranial Hemorrhages | 1 | 2019 | 855 | 0.120 |
Why?
|
Adrenoleukodystrophy | 1 | 2015 | 123 | 0.120 |
Why?
|
Shigella dysenteriae | 1 | 2013 | 14 | 0.120 |
Why?
|
Epithelial Cells | 2 | 2005 | 3690 | 0.120 |
Why?
|
Venous Thrombosis | 2 | 2014 | 1239 | 0.110 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2020 | 828 | 0.110 |
Why?
|
Vasculitis | 2 | 2008 | 519 | 0.110 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2014 | 284 | 0.110 |
Why?
|
Citrates | 2 | 2012 | 131 | 0.110 |
Why?
|
Demyelinating Diseases | 1 | 2015 | 354 | 0.110 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2013 | 139 | 0.110 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 560 | 0.100 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12959 | 0.100 |
Why?
|
Triiodobenzoic Acids | 3 | 1996 | 124 | 0.100 |
Why?
|
Prothrombin | 2 | 2002 | 185 | 0.100 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2012 | 141 | 0.100 |
Why?
|
Shear Strength | 1 | 2012 | 165 | 0.100 |
Why?
|
Animals | 22 | 2019 | 168757 | 0.100 |
Why?
|
Complement Inactivator Proteins | 1 | 1991 | 79 | 0.100 |
Why?
|
Kidney | 3 | 2019 | 7186 | 0.100 |
Why?
|
Microvessels | 1 | 2015 | 544 | 0.100 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 1991 | 31 | 0.100 |
Why?
|
Coronary Disease | 4 | 1996 | 6077 | 0.100 |
Why?
|
Glomerulonephritis, Membranous | 2 | 2008 | 86 | 0.090 |
Why?
|
Cell-Derived Microparticles | 1 | 2012 | 168 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 934 | 0.090 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 1991 | 188 | 0.090 |
Why?
|
Hematoma, Subdural | 1 | 1991 | 126 | 0.090 |
Why?
|
Microcephaly | 1 | 2014 | 432 | 0.090 |
Why?
|
Vitamin K Deficiency Bleeding | 2 | 2004 | 10 | 0.090 |
Why?
|
Thrombophlebitis | 1 | 1991 | 309 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2015 | 1730 | 0.090 |
Why?
|
Antibodies, Monoclonal | 3 | 2016 | 9274 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2013 | 547 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4751 | 0.080 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 868 | 0.080 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2010 | 103 | 0.080 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 1017 | 0.080 |
Why?
|
Adenosine Diphosphate | 3 | 1978 | 425 | 0.080 |
Why?
|
Erythrocyte Aggregation | 1 | 1988 | 36 | 0.080 |
Why?
|
Cattle | 7 | 1991 | 3922 | 0.080 |
Why?
|
Platelet Transfusion | 1 | 2012 | 314 | 0.080 |
Why?
|
Phlebitis | 1 | 2008 | 31 | 0.080 |
Why?
|
Vena Cava, Inferior | 1 | 2011 | 440 | 0.080 |
Why?
|
Adolescent | 12 | 2020 | 85781 | 0.080 |
Why?
|
Mice | 5 | 2019 | 81183 | 0.080 |
Why?
|
Rho(D) Immune Globulin | 1 | 2007 | 34 | 0.080 |
Why?
|
Escherichia coli | 1 | 2019 | 4217 | 0.080 |
Why?
|
Vitamin K | 2 | 2004 | 295 | 0.070 |
Why?
|
Diatrizoate Meglumine | 3 | 1993 | 83 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14557 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.070 |
Why?
|
Skin Diseases, Papulosquamous | 1 | 2006 | 18 | 0.070 |
Why?
|
Phospholipids | 1 | 1991 | 784 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1972 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2019 | 18029 | 0.070 |
Why?
|
Chorioamnionitis | 1 | 2008 | 155 | 0.070 |
Why?
|
Craniocerebral Trauma | 1 | 1991 | 482 | 0.070 |
Why?
|
Blood Coagulation Tests | 1 | 2007 | 263 | 0.070 |
Why?
|
Fibroblasts | 2 | 1995 | 4161 | 0.070 |
Why?
|
Anemia, Hemolytic | 1 | 2007 | 168 | 0.070 |
Why?
|
Leg | 1 | 2011 | 1116 | 0.070 |
Why?
|
Up-Regulation | 4 | 2015 | 4217 | 0.070 |
Why?
|
Blood Vessels | 1 | 2012 | 1125 | 0.070 |
Why?
|
Infant | 11 | 2022 | 35136 | 0.070 |
Why?
|
Equipment Design | 2 | 2012 | 3582 | 0.070 |
Why?
|
Adult | 15 | 2022 | 214055 | 0.070 |
Why?
|
Chromogenic Compounds | 1 | 2005 | 30 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2020 | 21746 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1061 | 0.070 |
Why?
|
Hospitals, Pediatric | 1 | 2014 | 1775 | 0.060 |
Why?
|
Dura Mater | 1 | 2006 | 291 | 0.060 |
Why?
|
Microscopy, Fluorescence | 3 | 2005 | 2699 | 0.060 |
Why?
|
Ascites | 1 | 2006 | 344 | 0.060 |
Why?
|
Microcirculation | 2 | 2005 | 1286 | 0.060 |
Why?
|
Time Factors | 6 | 2020 | 40075 | 0.060 |
Why?
|
Factor VIII | 1 | 2006 | 347 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4560 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1477 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.060 |
Why?
|
Thrombocytopenia | 1 | 2012 | 1179 | 0.060 |
Why?
|
Signal Transduction | 2 | 2013 | 23403 | 0.060 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2645 | 0.060 |
Why?
|
Hemophilia A | 1 | 2006 | 351 | 0.060 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2007 | 233 | 0.060 |
Why?
|
Kidney Tubules, Proximal | 1 | 2005 | 416 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2007 | 759 | 0.060 |
Why?
|
Glycoproteins | 1 | 1991 | 2263 | 0.050 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2004 | 183 | 0.050 |
Why?
|
Lysine | 3 | 1993 | 1007 | 0.050 |
Why?
|
Erythrocytes | 1 | 2012 | 2455 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2017 | 3143 | 0.050 |
Why?
|
Antithrombin III | 1 | 2002 | 128 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2004 | 648 | 0.050 |
Why?
|
Male | 18 | 2020 | 350118 | 0.050 |
Why?
|
Antifibrinolytic Agents | 1 | 2004 | 254 | 0.050 |
Why?
|
Cell Adhesion | 2 | 2005 | 3144 | 0.050 |
Why?
|
Female | 21 | 2022 | 380194 | 0.050 |
Why?
|
Factor V | 1 | 2002 | 178 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 56430 | 0.050 |
Why?
|
Fibronectins | 1 | 2005 | 726 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3768 | 0.050 |
Why?
|
Flow Cytometry | 3 | 1996 | 5974 | 0.050 |
Why?
|
Aspirin | 4 | 1996 | 3282 | 0.050 |
Why?
|
Particle Size | 1 | 2005 | 1642 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2017 | 4262 | 0.050 |
Why?
|
Culture Techniques | 1 | 2001 | 554 | 0.050 |
Why?
|
Brain | 4 | 2015 | 26385 | 0.050 |
Why?
|
Iopamidol | 2 | 1991 | 191 | 0.040 |
Why?
|
Factor VII | 1 | 2000 | 139 | 0.040 |
Why?
|
Risk Factors | 8 | 2019 | 72290 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2002 | 426 | 0.040 |
Why?
|
Ganglioneuroma | 1 | 1999 | 57 | 0.040 |
Why?
|
Aorta, Thoracic | 1 | 1985 | 1082 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 3068 | 0.040 |
Why?
|
Cell Separation | 1 | 2005 | 1751 | 0.040 |
Why?
|
Placenta | 1 | 2008 | 1698 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 1991 | 2133 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4371 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2002 | 634 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7913 | 0.040 |
Why?
|
Lipoprotein(a) | 1 | 2002 | 435 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2006 | 2258 | 0.040 |
Why?
|
Radiotherapy Dosage | 3 | 2014 | 2879 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14722 | 0.040 |
Why?
|
Shiga-Toxigenic Escherichia coli | 1 | 2016 | 28 | 0.030 |
Why?
|
Interleukin-1 | 1 | 2000 | 1263 | 0.030 |
Why?
|
Cellulose | 1 | 1976 | 121 | 0.030 |
Why?
|
Dogs | 6 | 1978 | 3912 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2006 | 1622 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2012 | 19905 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2008 | 1671 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1130 | 0.030 |
Why?
|
Drug Combinations | 2 | 2007 | 1959 | 0.030 |
Why?
|
Models, Cardiovascular | 2 | 2002 | 996 | 0.030 |
Why?
|
Antigens | 1 | 2001 | 1466 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2016 | 418 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11366 | 0.030 |
Why?
|
RNA | 1 | 2005 | 2749 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 1976 | 378 | 0.030 |
Why?
|
Diarrhea | 1 | 2002 | 1348 | 0.030 |
Why?
|
Cyanosis | 1 | 2014 | 83 | 0.030 |
Why?
|
Complement Activation | 1 | 2016 | 453 | 0.030 |
Why?
|
Factor X | 1 | 1993 | 64 | 0.030 |
Why?
|
Protein C Deficiency | 1 | 1993 | 29 | 0.030 |
Why?
|
Hematologic Tests | 1 | 2014 | 240 | 0.030 |
Why?
|
Bleeding Time | 1 | 1993 | 89 | 0.030 |
Why?
|
Hematopoietic Cell Growth Factors | 1 | 1993 | 102 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2016 | 693 | 0.030 |
Why?
|
Drug Evaluation | 1 | 1994 | 647 | 0.030 |
Why?
|
Pregnancy | 4 | 2008 | 29144 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 707 | 0.030 |
Why?
|
Surface Properties | 2 | 1993 | 1184 | 0.030 |
Why?
|
Factor VIIa | 1 | 1993 | 101 | 0.030 |
Why?
|
Brain Injuries | 1 | 2004 | 2025 | 0.030 |
Why?
|
Bone Neoplasms | 2 | 1999 | 2529 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2022 | 77449 | 0.030 |
Why?
|
Video Recording | 2 | 1990 | 949 | 0.030 |
Why?
|
Diffusion Chambers, Culture | 1 | 1991 | 50 | 0.030 |
Why?
|
Motion | 2 | 1995 | 798 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11031 | 0.030 |
Why?
|
Blood Cell Count | 3 | 1978 | 403 | 0.030 |
Why?
|
Pressure | 1 | 1995 | 1203 | 0.030 |
Why?
|
Fibrinopeptide A | 1 | 1991 | 44 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 1155 | 0.020 |
Why?
|
Protein S | 1 | 1991 | 30 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 1995 | 1092 | 0.020 |
Why?
|
Middle Aged | 3 | 2020 | 213383 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1785 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1655 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1081 | 0.020 |
Why?
|
Antibodies | 2 | 2002 | 2460 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 604 | 0.020 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 518 | 0.020 |
Why?
|
Thromboxane B2 | 1 | 1990 | 152 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1991 | 683 | 0.020 |
Why?
|
Rabbits | 3 | 1985 | 4894 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1152 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 987 | 0.020 |
Why?
|
Ions | 1 | 1990 | 265 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 1991 | 336 | 0.020 |
Why?
|
Kinetics | 2 | 1993 | 6473 | 0.020 |
Why?
|
Eye Enucleation | 1 | 1989 | 128 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1970 | 0.020 |
Why?
|
Platelet Count | 1 | 2012 | 781 | 0.020 |
Why?
|
Aorta | 2 | 1989 | 2061 | 0.020 |
Why?
|
Methylprednisolone | 1 | 1991 | 387 | 0.020 |
Why?
|
Methods | 1 | 1989 | 1129 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5097 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 1677 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2804 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2016 | 2170 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2014 | 957 | 0.020 |
Why?
|
Densitometry | 2 | 1978 | 156 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 1977 | 1736 | 0.020 |
Why?
|
Chorion | 1 | 2008 | 117 | 0.020 |
Why?
|
Radiotherapy, High-Energy | 1 | 1988 | 228 | 0.020 |
Why?
|
Drug Eruptions | 1 | 1991 | 297 | 0.020 |
Why?
|
Diffusion | 3 | 1978 | 833 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 1995 | 1741 | 0.020 |
Why?
|
Fatty Acids | 1 | 2015 | 1809 | 0.020 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 1987 | 197 | 0.020 |
Why?
|
Subdural Effusion | 1 | 2006 | 19 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1991 | 2505 | 0.020 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2007 | 152 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2011 | 924 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1993 | 1701 | 0.020 |
Why?
|
Practice Guidelines as Topic | 4 | 2007 | 7279 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2014 | 35421 | 0.020 |
Why?
|
Hemoptysis | 1 | 2008 | 155 | 0.020 |
Why?
|
Haplorhini | 2 | 1978 | 552 | 0.020 |
Why?
|
Apnea | 1 | 2008 | 195 | 0.020 |
Why?
|
Necrosis | 1 | 1991 | 1643 | 0.020 |
Why?
|
Thrombectomy | 1 | 2011 | 680 | 0.020 |
Why?
|
Papaverine | 1 | 1985 | 46 | 0.020 |
Why?
|
Prednisone | 1 | 1991 | 1574 | 0.020 |
Why?
|
Papio | 2 | 1978 | 656 | 0.020 |
Why?
|
Losartan | 1 | 2007 | 299 | 0.020 |
Why?
|
Enalapril | 1 | 2007 | 327 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 1624 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2005 | 68 | 0.020 |
Why?
|
Papilledema | 1 | 2006 | 118 | 0.020 |
Why?
|
Visual Acuity | 1 | 2014 | 2530 | 0.020 |
Why?
|
Orbital Neoplasms | 1 | 1987 | 225 | 0.020 |
Why?
|
Hemolysis | 1 | 2007 | 420 | 0.020 |
Why?
|
Hematocrit | 2 | 1977 | 636 | 0.020 |
Why?
|
Calcimycin | 1 | 1985 | 222 | 0.020 |
Why?
|
Calibration | 1 | 2007 | 816 | 0.020 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2007 | 451 | 0.020 |
Why?
|
Sheep | 2 | 1978 | 1437 | 0.020 |
Why?
|
Angiotensin II | 1 | 2007 | 881 | 0.020 |
Why?
|
Arachidonic Acids | 1 | 1985 | 299 | 0.020 |
Why?
|
Abortion, Habitual | 1 | 2004 | 70 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2018 | 5317 | 0.010 |
Why?
|
Probability | 1 | 1989 | 2505 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2007 | 1525 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1985 | 219 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 21827 | 0.010 |
Why?
|
Models, Biological | 1 | 2000 | 9583 | 0.010 |
Why?
|
Arachidonic Acid | 1 | 1985 | 434 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 7023 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2004 | 666 | 0.010 |
Why?
|
Thrombin | 1 | 1985 | 598 | 0.010 |
Why?
|
Caspase 3 | 1 | 2005 | 758 | 0.010 |
Why?
|
Isoantibodies | 1 | 2006 | 679 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2014 | 63114 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.010 |
Why?
|
Warfarin | 1 | 1991 | 1496 | 0.010 |
Why?
|
Species Specificity | 2 | 1977 | 2478 | 0.010 |
Why?
|
Osteosarcoma | 1 | 1987 | 881 | 0.010 |
Why?
|
Caspases | 1 | 2005 | 928 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2006 | 1850 | 0.010 |
Why?
|
Rare Diseases | 1 | 2006 | 553 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39050 | 0.010 |
Why?
|
Retinal Detachment | 1 | 2006 | 411 | 0.010 |
Why?
|
Hand Strength | 1 | 2004 | 448 | 0.010 |
Why?
|
Blindness | 1 | 2006 | 617 | 0.010 |
Why?
|
Body Temperature | 1 | 2004 | 777 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2018 | 4584 | 0.010 |
Why?
|
Motor Skills | 1 | 2004 | 522 | 0.010 |
Why?
|
Imidazoles | 1 | 2007 | 1206 | 0.010 |
Why?
|
Incidence | 2 | 2013 | 20947 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 1987 | 1813 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1590 | 0.010 |
Why?
|
Acute Disease | 1 | 2011 | 7149 | 0.010 |
Why?
|
Chest Pain | 1 | 2008 | 1114 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2004 | 1588 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 1991 | 6489 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2005 | 1227 | 0.010 |
Why?
|
Cytokines | 1 | 1995 | 7322 | 0.010 |
Why?
|
Eye Diseases | 1 | 2006 | 669 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29063 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2006 | 1063 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4933 | 0.010 |
Why?
|
Femoral Neoplasms | 1 | 1999 | 77 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1375 | 0.010 |
Why?
|
Mathematics | 2 | 1978 | 728 | 0.010 |
Why?
|
Headache | 1 | 2006 | 1226 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1413 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10262 | 0.010 |
Why?
|
Perfusion | 1 | 2002 | 1360 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9648 | 0.010 |
Why?
|
Humerus | 1 | 1999 | 266 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2005 | 2126 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1991 | 5021 | 0.010 |
Why?
|
Swine | 2 | 1978 | 5917 | 0.010 |
Why?
|
Monocytes | 1 | 2006 | 2596 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2002 | 738 | 0.010 |
Why?
|
Prenatal Care | 1 | 2004 | 1092 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1901 | 0.010 |
Why?
|
Pyridines | 1 | 2007 | 2825 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6365 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2006 | 3508 | 0.010 |
Why?
|
Macaca | 1 | 1977 | 440 | 0.010 |
Why?
|
Seizures | 1 | 2008 | 2859 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10943 | 0.010 |
Why?
|
Recovery of Function | 1 | 2004 | 2925 | 0.010 |
Why?
|
Aged | 2 | 2017 | 163280 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2004 | 2795 | 0.010 |
Why?
|
Anticonvulsants | 1 | 2004 | 1916 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1999 | 740 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 17446 | 0.010 |
Why?
|
Copper | 1 | 1976 | 366 | 0.010 |
Why?
|
Tibia | 1 | 1999 | 1077 | 0.010 |
Why?
|
Body Weight | 1 | 2004 | 4669 | 0.010 |
Why?
|
Microscopy | 1 | 1978 | 903 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1999 | 760 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 3719 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1977 | 2557 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11524 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1978 | 2375 | 0.010 |
Why?
|
Massachusetts | 1 | 2004 | 8663 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 40561 | 0.010 |
Why?
|
Hemoglobins | 1 | 1977 | 1534 | 0.010 |
Why?
|
Sepsis | 1 | 2004 | 2593 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2015 | 57776 | 0.010 |
Why?
|
United States | 1 | 2018 | 69872 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1988 | 9239 | 0.010 |
Why?
|
Phenotype | 1 | 2007 | 16365 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2861 | 0.010 |
Why?
|
Epilepsy | 1 | 2004 | 3310 | 0.000 |
Why?
|
Prospective Studies | 1 | 2012 | 53288 | 0.000 |
Why?
|
Cognition | 1 | 2004 | 6770 | 0.000 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3507 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20129 | 0.000 |
Why?
|
Radiation Protection | 1 | 1988 | 419 | 0.000 |
Why?
|
Neoplasms | 1 | 2012 | 21683 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1970 | 3589 | 0.000 |
Why?
|
Extracorporeal Circulation | 1 | 1970 | 182 | 0.000 |
Why?
|